Myrtillier Macérat de jeunes pousses Bio
Food supplement declared in France, declaration No 2023-4-582, decision dated 14 April 2023
Myrtillier Macérat de jeunes pousses Bio, from LABORATOIRES MESSEGUE, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Vaccinium myrtillus 22.5 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- not provided
- Food business operator placing the product on the market
- LABORATOIRES MESSEGUE
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Dropper
- Daily dose
- 15 gouttes (soit 0,42 ml)
- Directions for use
- Prendre pendant 3 semaines, 5 à 15 gouttes (pures ou diluées dans un verre d'eau) le matin à jeun
- Not recommended (according to the manufacturer)
- Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Children (under 6), Children (under 10)
Declaration 242694, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Vaccinium myrtillus L. | Jeune pousse | Autre macérât | 22.5 mg |
Additives
E422
Other ingredients
Alcool, eau
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Une consommation excessive peut avoir des effets laxatifs.Ne convient pas aux enfants, femmes enceintes ou allaitantes.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vaccinium myrtillus L.
Read the warning, when it applies and the studies cited
BILBERRY - VACCINIUM MYRTILLUS - Buccal
Route of administration: Buccal (Blumenthal et al. 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 30 January 2026
BILBERRY - VACCINIUM MYRTILLUS - Oral
Route of administration: Oral (Blumenthal et al. 2000)
Cautions and warnings
Condition of application: Relief of diarrhea.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Myrtillier Macérat de jeunes pousses Bio: composition and regulation”, https://compoatlas.com/en/supplements/products/242694-myrtillier-macerat-de-jeunes-pousses-bio, updated 15 November 2026.